| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MNFR.201200131 |
| P698 | PubMed publication ID | 22930403 |
| P2093 | author name string | Ying Li | |
| Xiao-Xia Li | |||
| Xian-Li Zhou | |||
| Hong-Zhi Pan | |||
| Chang-Hao Sun | |||
| Dian-Jun Sun | |||
| Li-Xin Na | |||
| Man Meng | |||
| P2860 | cites work | Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes | Q27311242 |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids | Q29614194 | ||
| Dose translation from animal to human studies revisited | Q29618049 | ||
| IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 | Q29620059 | ||
| Lipoprotein lipase: structure, function, regulation, and role in disease | Q30874419 | ||
| Curcumin improves insulin resistance in skeletal muscle of rats | Q34103820 | ||
| Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research | Q34586944 | ||
| Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes | Q35144249 | ||
| Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity | Q36755382 | ||
| The importance of free fatty acids in the development of Type 2 diabetes. | Q36921672 | ||
| Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin | Q37104834 | ||
| Immunomodulatory effects of curcumin in allergy | Q37132949 | ||
| Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. | Q40128732 | ||
| Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice | Q42474348 | ||
| Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice | Q42801955 | ||
| Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis | Q44286346 | ||
| Comparison of yield, composition, and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques. | Q44617438 | ||
| Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. | Q45019045 | ||
| Effects of curcuminoid supplement on cardiac autonomic status in high-fat-induced obese rats. | Q46034595 | ||
| Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes | Q46082780 | ||
| Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters | Q46305546 | ||
| Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes | Q46406430 | ||
| Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice | Q46466155 | ||
| Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice | Q46655923 | ||
| Curcumin inhibits glucose production in isolated mice hepatocytes | Q46789948 | ||
| Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role | Q46977927 | ||
| Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. | Q50709746 | ||
| Turmeronol A and turmeronol B, new inhibitors of soybean lipoxygenase. | Q105198923 | ||
| P433 | issue | 9 | |
| P921 | main subject | placebo | Q269829 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1569-1577 | |
| P577 | publication date | 2012-08-29 | |
| P1433 | published in | Molecular Nutrition and Food Research | Q15751861 |
| P1476 | title | Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. | |
| P478 | volume | 57 |
| Q92511933 | Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development |
| Q91671335 | An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review |
| Q26866115 | Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin |
| Q92281989 | Antidiabetic Properties of Curcumin II: Evidence from In Vivo Studies |
| Q36031163 | Chemical constituents and biological research on plants in the genus Curcuma |
| Q92528383 | Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment |
| Q38871530 | Curcumin and insulin resistance-Molecular targets and clinical evidences. |
| Q61443515 | Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial |
| Q47769067 | Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives |
| Q39052351 | Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms |
| Q91742577 | Curcumin in Autoimmune and Rheumatic Diseases |
| Q58699640 | Curcumin, Cardiometabolic Health and Dementia |
| Q44093807 | Curcumin: A Review of Its' Effects on Human Health |
| Q55058294 | Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. |
| Q87043402 | Curcuminoids for the management of hypertriglyceridaemia |
| Q92355604 | Dietary curcumin enhances insulin clearance in diet-induced obese mice via regulation of hepatic PI3K-AKT axis and IDE, and preservation of islet integrity |
| Q37237145 | Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs |
| Q50126084 | Effect of Curcumin on Anthropometric Measures: A Systematic Review on Randomized Clinical Trials |
| Q93053019 | Efficacy of Curcumin on Aortic Atherosclerosis: A Systematic Review and Meta-Analysis in Mouse Studies and Insights into Possible Mechanisms |
| Q51288303 | Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. |
| Q92457817 | Influence of curcumin supplementation on metabolic and lipid parameters of people living with HIV/AIDS: a randomized controlled trial |
| Q55057905 | Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. |
| Q47398352 | Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials |
| Q38253091 | Mitochondria as a target in the therapeutic properties of curcumin. |
| Q55284911 | Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer. |
| Q45200080 | More data needed on curcuminoids in hypertriglyceridaemia. |
| Q47199923 | Multifunctional Curcumin Mediate Multitherapeutic Effects |
| Q90632258 | Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy |
| Q91854901 | Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: A review of clinical trials |
| Q46284989 | Protective effects of curcumin against aflatoxicosis: A comprehensive review |
| Q64098106 | Retracted: Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis |
| Q48137778 | Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice. |
| Q38089715 | Targeted delivery of curcumin for treating type 2 diabetes. |
| Q90130423 | The Effect of Curcumin Supplementation and Aerobic Training on Anthropometric Indices, Serum Lipid Profiles, C-Reactive Protein and Insulin Resistance in Overweight Women: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q97542532 | The effect of 8 plant extracts and combinations on post-prandial blood glucose and insulin responses in healthy adults: a randomized controlled trial |
| Q64288322 | The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial |
| Q38819558 | Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. |
| Q90268957 | Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD) |
Search more.